跳至主要内容
临床试验/NCT04974190
NCT04974190Unknown不适用

A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients

The Grasses of Eden Ltd0 个研究点目标入组 550 人开始时间: 2021年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
550
主要终点
Symptoms monitoring

研究概览

简要总结

A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

详细描述

A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
16 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having tested positive to Covid-19 on PCR test -

排除标准

  • Pregnancy Low blood pressure On immune system suppressing medications

结局指标

主要结局

Symptoms monitoring

时间窗: First 7 days after testing positive on PCR test

Monitoring any disease symptoms reported by patient

Covid-19 infection self-testing on days 2, 4 following testing positive on PCR test

时间窗: First 7 days after testing positive on PCR test

Testing using a self testing kit of the Quidel QuickView type

次要结局

未报告次要终点

研究者

发起方
The Grasses of Eden Ltd
申办方类型
Industry
责任方
Sponsor

相似试验